Status:
UNKNOWN
Outcomes and Prognostic Factors in COVID-19
Lead Sponsor:
Heinrich-Heine University, Duesseldorf
Conditions:
COVID-19
Elderly Patients
Eligibility:
All Genders
70+ years
Brief Summary
The primary aim is to study the short-term outcome of elderly ICU patients (≥ 70 years) suffering from COVID-19 using a multicenter and multi-national approach. The secondary aim is to investigate the...
Detailed Description
The study started in March 2020 and included until summer 2021 nearly 4000 patients. Several comprehensive analyses were conducted and published. Subsequently, in December 2021 the protocol was slight...
Eligibility Criteria
Inclusion
- Age \> 70 years
- ICU-Admission
- Infection with SARS-CoV-2
Exclusion
- 1\. Age \<70 years
Key Trial Info
Start Date :
March 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04321265
Start Date
March 19 2020
End Date
March 31 2023
Last Update
November 7 2022
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Intensive Care, Aarhus University Hospital
Aarhus, Denmark
2
Hôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale
Paris, France
3
INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique
Paris, France
4
Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique
Paris, France